Targeting inhibition of TCTP could inhibit proliferation and induce apoptosis in AML cells

Di Xia1, Gui-Ping Xu2, Ying-Ting Zhang1

  • 1Central Laboratory, Rui-jin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Rui-jin Er Road, Shanghai 200025, China.

Cellular Signalling
|February 3, 2024
PubMed

Insights

Translationally controlled tumor protein (TCTP) plays a key role in acute myeloid leukemia (AML) development. Inhibiting TCTP reduces AML cell proliferation and induces apoptosis, suggesting TCTP as a potential therapeutic target for AML.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Translationally controlled tumor protein (TCTP) is a conserved protein involved in critical physiological processes.
  • TCTP's roles in cell proliferation, apoptosis, and its association with various cancers are gaining attention.
  • Retinoic acid-induced gene G (RIG-G) acts as an anti-proliferative mediator in retinoid/interferon pathways.

Purpose of the Study:

  • To investigate the function of TCTP in the development of acute myeloid leukemia (AML).
  • To explore TCTP's potential as a therapeutic target for AML.

Main Methods:

  • Analyzing TCTP protein levels in AML cell lines and patient samples.
  • Evaluating the effects of TCTP inhibition on AML cell proliferation and apoptosis in vitro.
  • Assessing TCTP inhibition in a xenograft mouse model of AML.

Main Results:

  • TCTP protein levels were reduced in NB4 cells transfected with RIG-G.
  • Inhibiting TCTP expression attenuated AML cell proliferation and induced apoptosis in cell lines and xenografts.
  • Elevated TCTP expression was observed in bone marrow of AML patients compared to remission and non-leukemia controls.

Conclusions:

  • TCTP is implicated in AML development and progression.
  • TCTP inhibition demonstrates anti-leukemic effects.
  • TCTP represents a potential therapeutic target for acute myeloid leukemia treatment.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K